Aug. 20, 2021 — The Pharmaceutical Research and Manufacturers of America (PhRMA) has “updated and enhanced” its voluntary code of ethics regarding how the drug industry can appropriately interact with U.S. health care professionals (HCPs) while marketing biopharma products in various ways, including speaker programs. PhRMA’s revised “Code on Interactions with Health Care Professionals,” last updated […]
Read more
Sept. 27, 2018 – Although it was the Obama administration’s position that reprints and textbooks received by physicians were transfers of value that were fully reportable under the Sunshine Act Open Payments regulation, the Trump administration and Congress are taking another look at the matter, according to John Kamp, Washington Counsel, Coalition for Healthcare Communication. […]
Read more Oct. 6, 2016 – The Centers for Medicare & Medicaid Services (CMS) recently clarified in a revised FAQ that manufacturers that provide a payment or transfer of value to support continuing medical education (CME) but do not specify that the CME provider should offer payment to a specific physician speaker or faculty member would not […]
Read moreOct. 12, 2015 – A bill introduced in the Senate last week by Sen. Charles Grassley (R-Iowa) and Sen. Richard Blumenthal (D-Conn.) would broaden Sunshine Act Open Payments reporting to nurse practitioners and physician assistants, according to a recent article in Policy and Medicine. “Although Senators Grassley and Blumenthal are true believers, it’s probably premature […]
Read moreAug. 18, 2014 – The Centers for Medicare & Medicaid Services (CMS) recently announced that it had reopened its Open Payments Website and would extend the period during which physicians can review and request corrections to their Physician Sunshine Act records, according to an Aug. 15 article in Policy and Medicine. The agency had taken […]
Read more